Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Nanomedicine Journal. 2013; 1 (1): 38-47
in English | IMEMR | ID: emr-171613

ABSTRACT

Topical retinoids are considered as the first line therapy in the treatment of acne vulgaris, but they are associated with cutaneous irritation. In this study, isotretinoin-loaded solid lipid nanoparticles [IT-SLN] were prepared to treat the mild to moderate acne. Also using IT-SLN would minimize IT adverse effects in comparison to commercial product, Isotrex. This study was conducted to prepare and characterize IT-SLN and assessing the efficiency of IT-SLN comparing to Isotrex acne. IT-SLN was prepared using hot high pressure homogenization method. IT-SLN contained 0.05% IT in 5% of lipid phase [Glyceryl monostearate- GMS] and tween 80 [2.5% w/v] was used as surfactant in the aqueous phase. IT-SLN was characterized by particle size analyzing, differential scanning calorimetry and transmission electron microscopy. Encapsulation efficacy was also obtained using spectrophotometry. The efficacy of IT-SLN was evaluated in a randomized, single-blind, parallel-group study and compared with Isotrex. Forty patients encountered in the study and divided in two groups. Treatment regimen was once-nightly topical administration accompanied with topical administration of clindamycin 2% solution twice a day for 8 weeks. The particle size of IT-SLN was around 60 nm with PDI of 0.4 and zeta potential was about -40 mV. Encapsulation efficacy of IT in SLN in crystalline form was 84 +/- 0.21%. IT-SLN produced significantly better treatment than Isotrex in both non-inflammatory and inflammatory lesions according to its recovery percent after 8 weeks. Also IT-SLN gained better global assessment scores. Our results showed that IT-SLN had higher efficacy than Isotrex to clear non-inflammatory and inflammatory lesions


Subject(s)
Humans , Male , Female , Adolescent , Adult , Isotretinoin , Lipids , Nanoparticles , Single-Blind Method
2.
Avicenna Journal of Phytomedicine [AJP]. 2012; 2 (1): 17-23
in English | IMEMR | ID: emr-151620

ABSTRACT

Platycladus orientalis or Thuja orientalis is a native plant of Iran different parts of which are used in the treatment of various diseases such as: gout, rheumatoid arthritis, common cold, cough, bronchitis, asthma, high blood pressure and hormonal disorders like hirsutism and baldness. Also, various organs of this species have been used as appetizer. The purpose of this study was to prepare and characterize liposomal formulations that contain methanol extract of aerial parts of P. orientalis for hirsutism treatment. Plant's leaves were dried in room temperature, and powdered by grinding. Then, methanol extract was prepared by maceration method. Liposomes containing mathanol extract were produced by two methods of fusion and solvent evaporation. To evaluate mathanol extract and encapsulation efficiency of liposomes, quercetin was chosen as standard. The amount of quercetin in samples was determined by high pressure liquid chromatography [HPLC] method. Mean size of liposomes prepared by solvent evaporation and fusion methods was 373 and 320 nm, respectively. According to the quercetin concentration, encapsulation efficiency of liposomes containing menthanol extract was 69.3 +/- 3.1% for solvent evaporation and 62.2 +/- 4.9% for fusion method. In the current study, a suitable liposomal formulation was prepared. The pharmacological activity of these carriers should be evaluated in the future study

SELECTION OF CITATIONS
SEARCH DETAIL